Laurent Prézeau

Author PubWeight™ 32.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther 2003 3.36
2 Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods 2008 2.88
3 Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat Struct Mol Biol 2004 2.58
4 Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J 2005 1.72
5 Asymmetric functioning of dimeric metabotropic glutamate receptors disclosed by positive allosteric modulators. J Biol Chem 2005 1.55
6 A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor. J Biol Chem 2001 1.49
7 Dimers and beyond: The functional puzzles of class C GPCRs. Pharmacol Ther 2011 1.48
8 The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. J Biol Chem 2004 1.45
9 Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. Proc Natl Acad Sci U S A 2003 1.44
10 Activation mechanism of the heterodimeric GABA(B) receptor. Biochem Pharmacol 2004 1.34
11 Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. EMBO J 2009 1.32
12 Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol Pharmacol 2007 1.17
13 Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors. J Biol Chem 2007 1.13
14 The oligomeric state sets GABA(B) receptor signalling efficacy. EMBO J 2011 1.05
15 A model for the functioning of family 3 GPCRs. Trends Pharmacol Sci 2002 0.99
16 Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective. Curr Neuropharmacol 2007 0.98
17 The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptors. Neuropharmacology 2010 0.96
18 The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation. Biochem J 2010 0.95
19 The second intracellular loop of metabotropic glutamate receptors recognizes C termini of G-protein alpha-subunits. J Biol Chem 2003 0.89
20 Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to G protein-coupled receptor oligomerization. Methods Mol Biol 2011 0.84
21 Among the twenty classical L-amino acids, only glutamate directly activates metabotropic glutamate receptors. Neuropharmacology 2005 0.83
22 Further insights into GPR179: expression, localization, and associated pathogenic mechanisms leading to complete congenital stationary night blindness. Invest Ophthalmol Vis Sci 2013 0.81
23 Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. Mol Cell Proteomics 2014 0.79
24 Amino-pyrrolidine tricarboxylic acids give new insight into group III metabotropic glutamate receptor activation mechanism. Mol Pharmacol 2006 0.77
25 Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling. AIDS 2017 0.75
26 Time-resolved Förster resonance energy transfer-based technologies to investigate G protein-coupled receptor machinery: high-throughput screening assays and future development. Prog Mol Biol Transl Sci 2013 0.75